Cargando…
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
Several compounds bearing the indolinone chemical scaffold are known to possess anticancer properties. For example, the tyrosine kinase inhibitor sunitinib is an arylideneindolin-2-one compound. The chemical versatility associated with structural modifications of indolinone compounds underlies the p...
Autores principales: | Kaminska, Kamila K., Bertrand, Helene C., Tajima, Hisashi, Stafford, William C., Cheng, Qing, Chen, Wan, Wells, Geoffrey, Arner, Elias S.J., Chew, Eng-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130005/ https://www.ncbi.nlm.nih.gov/pubmed/27244886 http://dx.doi.org/10.18632/oncotarget.9579 |
Ejemplares similares
-
Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone
por: Shu, Nan, et al.
Publicado: (2019) -
Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase
por: Prigge, Justin R., et al.
Publicado: (2017) -
Cytosolic thioredoxin reductase 1 is required for correct disulfide formation in the ER
por: Poet, Greg J, et al.
Publicado: (2017) -
Molecular Basis for the Interactions of Human Thioredoxins with Their Respective Reductases
por: Hossain, Md Faruq, et al.
Publicado: (2021) -
Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness
por: Peng, Xiaoxiao, et al.
Publicado: (2016)